厄贝沙坦对高血压合并慢性肾功能不全影响观察与体会.docVIP

厄贝沙坦对高血压合并慢性肾功能不全影响观察与体会.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
厄贝沙坦对高血压合并慢性肾功能不全影响观察与体会

厄贝沙坦对高血压合并慢性肾功能不全影响观察与体会   [摘要] 目的:观察与分析厄贝沙坦治疗高血压合并慢性肾功能不全的效果。方法:将80例高血压合并慢性肾功能不全患者随机分为两组,即观察组和对照组,每组40例,同时给予两组患者相应治疗措施且对其临床治疗效果、血压控制和肾功能等方面进行观察与相关数据统计分析。结果:观察组治疗总有效率为70%,优于对照组(50%),同时治疗后观察组研究对象收缩压为(135.13±15.34)mm Hg,舒张压为(74.00±8.43)mm Hg,均好于对照组(t=10.75、12.30,均P<0.05);观察组血肌酐为(176.0±26.2)μmol/L,尿素氮为(9.7±3.0)mmol/L,尿蛋白为(1.62±0.23)g/24 h,三者均好于对照组(t=11.86、13.84、12.54,均P<0.05)。结论:厄贝沙坦治疗高血压合并慢性肾功能不全效果显著,不仅可以有效控制血压,同时对改善肾功能,延缓病情进展具有十分重要的临床意义。   [关键词] 厄贝沙坦;高血压;慢性肾功能不全;观察   [中图分类号] R544.1 [文献标识码] A [文章编号] 1673-7210(2011)11(c)-076-02      Observation and experience of influence on Irbesartan for hypertension and chronic renal insufficiency   CHEN Yiquan, ZHUANG Manru   Department of Internal Medicine, Chaozhou Central Hospital, Guangdong Province, Chaozhou 521000, China   [Abstract] Objective: To observe and analyze the efficacy of Irbesartan in the treatment of hypertension and chronic renal insufficiency. Methods: 80 patients with hypertension and chronic renal failure were randomly divided into two groups, the observation group and control group, with 40 cases in each group. The appropriate treatment was given in two groups and the clinical efficacy, blood pressure control and kidney function of patients in two groups were observed and the data were analyzed. Results: The total effective rate was 70% in the observation group, better than the control group (50%). While after treatment in the observation group, the systolic blood pressure of subject was (135.13±15.34) mm Hg, the diastolic blood pressure was (74.00±8.43) mm Hg, both of which were better than the control group (t=10.75, 12.30, all P<0.05); the serum creatinine of the observation group was (176.0±26.2) μmol/L, the urea nitrogen was (9.7±3.0) mmol/L, the urinary protein was (1.62±0.23) g/24 h, all of which were better than the control group (t=11.86, 13.84, 12.54, all P<0.05). Conclusion: The treatment of Irbesartan for hypertension and chronic renal insufficiency has an obvious efficacy. It not only c

文档评论(0)

3471161553 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档